Long-term experience with integral photodynamic therapy of TIS bladder carcinoma
- PMID: 2534070
- DOI: 10.1002/9780470513842.ch14
Long-term experience with integral photodynamic therapy of TIS bladder carcinoma
Abstract
Fifteen patients in whom superficial bladder tumours (TIS GII-III) recurred after the unsuccessful application of other treatments were treated by photodynamic therapy (PDT) and observed for 24-54 months. The results of therapy were evaluated by regular three-monthly check-ups (endoscopy, cytology, bladder mapping, renal ultrasonography) as well as by computed tomography (CT) examination at 8- to 13-month intervals. In nine patients treated by PDT no tumour recurrence has been found over the whole observation period. Two patients have remained free of tumour (12 and 14 months) after repeated transurethral resection (TUR) and Nd-YAG laser therapy after PDT. Two patients required a second application of PDT before the treatment goal was achieved. In one of these cases a circumscribed dysplasia which appeared at the left ostium 26 months after PDT was treated by TUR and Nd-YAG laser. Further observations showed it had been successfully removed. In six patients slight mucosal atypia persisted for at least 2.5 years. In the short-term course of further cases (n = 12) one cystectomy has to be performed because of bladder shrinkage. According to these preliminary results, PDT (with strict patient selection--worst-case situation with recommended cystectomy) is justified for recurrent superficial TIS bladder carcinoma.
Similar articles
-
Clinical experience with the integral photodynamic therapy of bladder carcinoma.J Photochem Photobiol B. 1990 Jun;6(1-2):183-7. doi: 10.1016/1011-1344(90)85088-e. J Photochem Photobiol B. 1990. PMID: 2146378
-
Photodynamic therapy.Urol Clin North Am. 1992 Aug;19(3):591-9. Urol Clin North Am. 1992. PMID: 1386168 Review.
-
[Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].Urologe A. 1994 Jul;33(4):276-80. Urologe A. 1994. PMID: 7941172 German.
-
Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group.J Urol. 1998 Jul;160(1):39-44. J Urol. 1998. PMID: 9628601 Clinical Trial.
-
Photodynamic therapy for superficial bladder cancer.Expert Rev Anticancer Ther. 2001 Dec;1(4):523-30. doi: 10.1586/14737140.1.4.523. Expert Rev Anticancer Ther. 2001. PMID: 12113084 Review.
Cited by
-
[Photodynamic therapy of bladder cancer. A new option].Urologe A. 2013 Sep;52(9):1225-32. doi: 10.1007/s00120-013-3306-2. Urologe A. 2013. PMID: 24026059 Review. German.
-
Photodynamic Therapy: Current Trends and Potential Future Role in the Treatment of Bladder Cancer.Int J Mol Sci. 2024 Jan 12;25(2):960. doi: 10.3390/ijms25020960. Int J Mol Sci. 2024. PMID: 38256035 Free PMC article. Review.
-
Biological activities of phthalocyanines. XIV. Effect of hydrophobic phthalimidomethyl groups on the in vivo phototoxicity and mechanism of photodynamic action of sulphonated aluminium phthalocyanines.Br J Cancer. 1992 Jun;65(6):813-7. doi: 10.1038/bjc.1992.174. Br J Cancer. 1992. PMID: 1616852 Free PMC article.
-
Medical management of patients with refractory carcinoma in situ of the bladder.Drugs Aging. 2001;18(5):335-44. doi: 10.2165/00002512-200118050-00004. Drugs Aging. 2001. PMID: 11392442 Review.
-
The use of photodynamic therapy in medical practice.Front Oncol. 2024 May 8;14:1373263. doi: 10.3389/fonc.2024.1373263. eCollection 2024. Front Oncol. 2024. PMID: 38803535 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical